--- title: "TalkSpace | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 61.68 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/285997786.md" datetime: "2026-05-11T21:06:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285997786.md) - [en](https://longbridge.com/en/news/285997786.md) - [zh-HK](https://longbridge.com/zh-HK/news/285997786.md) --- # TalkSpace | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 61.68 M Revenue: As of FY2026 Q1, the actual value is USD 61.68 M, missing the estimate of USD 64.27 M. EPS: As of FY2026 Q1, the actual value is USD -0.04. EBIT: As of FY2026 Q1, the actual value is USD -7.907 M. Talkspace, Inc. operates as a single segment, with consolidated results reviewed by its Chief Executive Officer for management and resource allocation purposes . #### Segment Revenue - **Total Revenue**: Increased by 18.2% to $61,679 thousand for the three months ended March 31, 2026, from $52,182 thousand for the same period in 2025, primarily driven by volume and a shift in revenue mix towards Payor customers . - **Payor Revenue**: Grew by 28.3% to $48,562 thousand in Q1 2026, from $37,842 thousand in Q1 2025, attributed to a 31.2% increase in completed Payor sessions, a 26.4% increase in unique active Payor members, and a 12.9% increase in health plan customers . - **DTE Revenue**: Remained stable at $9,613 thousand in Q1 2026, compared to $9,583 thousand in Q1 2025 . - **Consumer Revenue**: Decreased by 26.3% to $3,504 thousand in Q1 2026, from $4,757 thousand in Q1 2025, mainly due to a 23.9% decrease in Consumer active members as a result of a strategic focus on Payor members . #### Operational Metrics - **Net (Loss) Income**: Talkspace, Inc. reported a net loss of - $6,306 thousand for Q1 2026, a decrease from a net income of $318 thousand for Q1 2025 . - **Loss from Operations**: Increased to - $7,127 thousand in Q1 2026, from - $1,085 thousand in Q1 2025 . - **Cost of Revenue (excluding depreciation and amortization)**: Increased by 25.3% to $36,064 thousand in Q1 2026, from $28,789 thousand in Q1 2025, primarily due to increased therapist hours from higher Payor sessions . - **Research and Development Expenses**: Decreased by 6.2% to $2,664 thousand in Q1 2026, from $2,840 thousand in Q1 2025, mainly due to a decrease in employee-related costs after excluding capitalized internal-use software development costs . - **Clinical Operations Expenses**: Remained relatively unchanged at $1,874 thousand in Q1 2026, compared to $1,856 thousand in Q1 2025 . - **Sales and Marketing Expenses**: Remained relatively unchanged at $13,849 thousand in Q1 2026, compared to $13,926 thousand in Q1 2025 . - **General and Administrative Expenses**: Increased by 146.2% to $12,818 thousand in Q1 2026, from $5,207 thousand in Q1 2025, primarily due to $7,300 thousand in transaction-related costs for the merger with UHS . - **Depreciation and Amortization Expenses**: Increased by 136.8% to $1,537 thousand in Q1 2026, from $649 thousand in Q1 2025, mainly due to a $700 thousand increase in amortization expense from capitalized internal-use software assets . - **Financial Income, Net**: Decreased by 38.1% to - $945 thousand in Q1 2026, from - $1,526 thousand in Q1 2025, largely due to a $400 thousand decrease in interest income from marketable securities from reduced interest rates . - **Adjusted EBITDA**: Increased to $4,649 thousand in Q1 2026, from $1,955 thousand in Q1 2025 . #### Unique Metrics - **Number of completed Payor sessions**: 459.3 thousand in Q1 2026, up from 350.0 thousand in Q1 2025 . - **Number of health plan customers**: 38 at March 31, 2026, compared to 31 at March 31, 2025 . - **Number of enterprise customers**: 153 at March 31, 2026, compared to 173 at March 31, 2025 . - **Number of Consumer active members**: 5.2 thousand at March 31, 2026, down from 6.9 thousand at March 31, 2025 . - **Unique active Payor members**: 128.0 thousand in Q1 2026, up from 101.2 thousand in Q1 2025 . #### Cash Flow - **Net Cash Used in Operating Activities**: - $4,418 thousand for Q1 2026, compared to - $1,239 thousand for Q1 2025, primarily due to unfavorable timing of customer payments and net loss . - **Net Cash Used in Investing Activities**: - $793 thousand for Q1 2026, a decrease from - $9,019 thousand for Q1 2025, driven by increased proceeds from marketable securities maturities and reduced purchases, partially offset by higher capitalized internal-use software costs . - **Net Cash Used in Financing Activities**: - $730 thousand for Q1 2026, a decrease from - $6,357 thousand for Q1 2025, mainly due to no stock repurchases in Q1 2026 compared to $7,000 thousand in repurchases in Q1 2025 . #### Future Outlook and Strategy Talkspace, Inc. entered into a definitive merger agreement with Universal Health Services, Inc. (UHS) on March 9, 2026, for UHS to acquire all outstanding shares for $5.25 per share in cash, valuing the transaction at approximately $835.0 million . The merger is expected to close in the third quarter of 2026, subject to customary conditions and stockholder approval . Talkspace, Inc. anticipates funding its cash needs for at least the next 12 months and the foreseeable future using available cash and cash equivalents . ### Related Stocks - [TALK.US](https://longbridge.com/en/quote/TALK.US.md) ## Related News & Research - [Talkspace Chief Legal Officer John C. Reilly sells 40,289 shares worth $209,508.94](https://longbridge.com/en/news/290495431.md) - [Rithm Q2 2026 GAAP net income drops to $20.2 million; earnings available for distribution rises to $338.9 million](https://longbridge.com/en/news/294051913.md) - [Blackstone 2Q FY26 net income attributable to Blackstone rises 61% to $1.23 billion](https://longbridge.com/en/news/293603740.md) - [Visteon Q2 FY26 net income drops 30.99% to USD 49 million; net sales fall 0.93% to USD 960 million](https://longbridge.com/en/news/293602288.md) - [Provident Financial Holdings Reports Strong Quarterly Earnings Growth](https://longbridge.com/en/news/294095020.md)